Literature DB >> 11245282

Molecular mechanisms of tumor angiogenesis and tumor progression.

U Cavallaro1, G Christofori.   

Abstract

The formation of new blood vessels (angiogenesis) is crucial for the growth and persistence of primary solid tumors and their metastases. Furthermore, angiogenesis is also required for metastatic dissemination, since an increase in vascular density will allow easier access of tumor cells to the circulation. Induction of angiogenesis precedes the formation of malignant tumors, and increased vascularization seems to correlate with the invasive properties of tumors and thus with the malignant tumor phenotype. In the last few years, the discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. However, although angiogenesis appears to be a rate-limiting event in tumor growth and metastatic dissemination, a direct connection between the induction of angiogenesis and the progression to tumor malignancy is less well understood. In this review, we discuss the most recent observations concerning the modulation of angiogenesis and their implications in tumor progression, as well as their potential impact on cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11245282     DOI: 10.1023/a:1006414621286

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  77 in total

1.  Endostatin induces endothelial cell apoptosis.

Authors:  M Dhanabal; R Ramchandran; M J Waterman; H Lu; B Knebelmann; M Segal; V P Sukhatme
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

2.  Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma.

Authors:  D Giri; M Ittmann
Journal:  Hum Pathol       Date:  1999-04       Impact factor: 3.466

3.  Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth.

Authors:  G A Homandberg; J E Williams; D Grant; B Schumacher; R Eisenstein
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

4.  Inhibitory effect of full-length human endostatin on in vitro angiogenesis.

Authors:  L Taddei; P Chiarugi; L Brogelli; P Cirri; L Magnelli; G Raugei; M Ziche; H J Granger; V Chiarugi; G Ramponi
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

5.  Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.

Authors:  J Kandel; E Bossy-Wetzel; F Radvanyi; M Klagsbrun; J Folkman; D Hanahan
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

6.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

7.  Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.

Authors:  M D Johnson; H R Kim; L Chesler; G Tsao-Wu; N Bouck; P J Polverini
Journal:  J Cell Physiol       Date:  1994-07       Impact factor: 6.384

8.  Tumor induction of VEGF promoter activity in stromal cells.

Authors:  D Fukumura; R Xavier; T Sugiura; Y Chen; E C Park; N Lu; M Selig; G Nielsen; T Taksir; R K Jain; B Seed
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

9.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  34 in total

Review 1.  Bevacizumab increases risk for severe proteinuria in cancer patients.

Authors:  Shenhong Wu; Christi Kim; Lea Baer; Xiaolei Zhu
Journal:  J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 10.121

2.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

Authors:  Yelena Mironchik; Paul T Winnard; Farhad Vesuna; Yoshinori Kato; Flonne Wildes; Arvind P Pathak; Scott Kominsky; Dmitri Artemov; Zaver Bhujwalla; Paul Van Diest; Horst Burger; Carlotta Glackin; Venu Raman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  Effects of the angiogenesis inhibitor angiostatin on the growth of CC531 colon carcinoma cells in vitro and in a laparoscopic animal model of peritoneal carcinomatosis.

Authors:  G Nestler; H U Schulz; J Tautenhahn; R Kuhn; S Krüger; H Lippert; M Pross
Journal:  Int J Colorectal Dis       Date:  2005-10-05       Impact factor: 2.571

Review 4.  α7 nicotinic acetylcholine receptors in lung cancer.

Authors:  Shengchao Wang; Yue Hu
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

5.  The inhibitory effects of 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on human colon cancer cells.

Authors:  Peiju Qiu; Huashi Guan; Ping Dong; Shanshan Guo; Jinkai Zheng; Shiming Li; Yun Chen; Chi-Tang Ho; Min-Hsiung Pan; David Julian McClements; Hang Xiao
Journal:  Mol Nutr Food Res       Date:  2011-06-06       Impact factor: 5.914

Review 6.  Brain metastases: biology and the role of the brain microenvironment.

Authors:  V K Puduvalli
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

7.  Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma.

Authors:  Pei-Yuan Li; Ju-Sheng Lin; Zuo-Hua Feng; Yu-Fei He; He-Jun Zhou; Xin Ma; Xiao-Kun Cai; De-An Tian
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

8.  N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo.

Authors:  Dahai Wang; Oscar A Carretero; Xiao-Yi Yang; Nour-Eddine Rhaleb; Yun-He Liu; Tang-Dong Liao; Xiao-Ping Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-15       Impact factor: 4.733

9.  Glioblastoma multiforme.

Authors:  Herbert B Newton
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

10.  Correlating gene and protein expression data using Correlated Factor Analysis.

Authors:  Chuen Seng Tan; Agus Salim; Alexander Ploner; Janne Lehtiö; Kee Seng Chia; Yudi Pawitan
Journal:  BMC Bioinformatics       Date:  2009-09-01       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.